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Interleukin 7 (IL-7) has been demonstrated to be an important regulator of the growth of B 
and T cell precursors as well as mature T cells, whereas IL-7 has been reported to have no direct 
myeloproliferative effects. Here we show that IL-7 potently and directly enhances colony stimulating 
factor-induced myeloid colony formation from Lin-Sca-1 §  murine bone marrow progenitor 
cells, increasing the cloning frequency up to ninefold and cell numbers up to 50-fold, without 
affecting their ability to differentiate along the myeloid lineages In contrast, IL-7 has no effect 
on proliferation of committed Lin-  myeloid progenitors. Thus, in addition to its established 
lymphopoietic potential,  this study implicates a novel role of IL-7 in early myelopoiesis. 
T 
he hematopoietic system is organized in a hierarchical 
fashion, with the infrequent pluripotent hematopoietic 
stem cell at the top, capable of replenishing all cell lineages 
in the blood (1-3). This pluripotent stem cell gives rise to 
intermediate multipotent, bipotent, and unipotent myeloid 
progenitors as well as unipotent B and T cell precursors. Re- 
cently, the existence of bipotential precursors of B cells and 
macrophages has been demonstrated as well (4). The prolifer- 
ation and differentiation of this diversity of hematopoietic 
progenitors and stem cells are controlled by a complex system 
of cell-cell interactions and soluble hematopoietic growth 
factors (HGFs) (3,  5-7).  Whereas single HGFs can induce 
proliferation and differentiation of committed hematopoietic 
progenitor cells, optimal proliferation of immature progen- 
itor cells can only be achieved when multiple HGFs act in 
synergy (3).  Even though  a  number of HGFs  have been 
demonstrated to stimulate proliferation of  bone marrow stem 
cells, no known growth factor combination is capable of in- 
ducing proliferation to the extent observed when stem cells 
are cocultured with stroma feeder layers (8). Stem cell to stroma 
cell interactions are thought to be important for stem cell 
proliferation, but it also seems likely that not yet identified 
HGFs might enhance the proliferative capacity of immature 
hematopoietic stem cells. 
G-CSF, CSF-1 (M-CSF), and GM-CSF represent a group 
of CSFs capable of inducing growth of only myeloid progen- 
itor cells, whereas most HGFs stimulating B cell lymphopoiesis 
(such as IL-3, -4, -5, -6, -11, and stem cell factor [SCF]) have 
myeloproliferative effects as well (9-13). In fact, IL-7 is the 
only  HGF  reported  to  stimulate  proliferation  of B  cell 
precursors but not myeloid progenitors (14-18). Furthermore, 
IL-7 potently enhances the growth of T cell precursors (19) 
and mature T  cells (20).  The expression of IL-7 receptors 
on myeloid cells (21) as well as the effects of IL-7 on my- 
elopoiesis in vivo (22, 23) suggest that IL-7 might also have 
myeloproliferative effects, however, the only reported in vitro 
effect of IL-7 on myeloid cells is its ability to induce tumori- 
cidal activity and secretion of IL-1, IL-6, and TNF-oe by mono- 
cytes (24). Since previous studies (14-18) reporting that IL-7 
lacks myeloproliferative effects have not used populations of 
primitive hematopoietic progenitors, this study was designed 
to examine direct myeloproliferative effects of IL-7 in vitro 
on a population of highly enriched primitive routine hema- 
topoietic progenitor cells,  the Lin-Sca-1 + cells. As few as 
100 of these cells can rescue 50% of lethally irradiated mice, 
and long-term, reconstitute all lineages in the blood (2, 25, 
and Veiby, O.  P.,  unpublished results). 
Materials and Methods 
Growth Factors.  Purified recombinant human (rh) IL-7 was a 
gift from Steven Giilis (Immunex Corp., Seattle, WA). rhG-CSF 
and r routine (rm) GM-CSF were generously supplied by Ian K. 
McNiece (Amgen Corp., Thousand Oaks, CA); rmlL-3 was pur- 
chased from Promega Corp. (Madison, WI); and rCSF-1 was kindly 
supplied by Michael Geier (Cetus Corp.,  Emeryviile, CA). 
Unless otherwise  indicated, all growth factors were used at 
predetermined  optimal  concentrations:  rmGM-CSF,  20 ng/ml; 
rhCSF-1, 50 ng/ml; rhG-CSF, 20 ng/ml; rmIb3, 20 ng/ml; and 
rhlL-7, 200 ng/ml. 
Enrichment and Purification of Bone Marrow Progenitors.  Lin- 
ceils were isolated from normal C57BL mice, according to a previ- 
ously described protocol (2). Briefly, light density bone marrow 
ceils were obtained using lymphocyte separation medium (Lym- 
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twice in IMDM (Gibco, Paisley, UK), and resuspended in IMDM 
supplemented with 20% FCS (Sera-Lab Ltd., Sussex,  UK),  100 
U/ml penicillin,  and 3 mg/ml glutamine (complete IMDM). The 
cells were incubated at 4~  for 30 min in a cocktail of predeter- 
mined optimal concentrations of Abs,  RA3-6B2 (B220 antigen; 
PharMingen,  San Diego, CA), RB6-8C5 (GK-1 antigen; Phar- 
Mingen), MAC-1 (Serotec, Oxfordshire, UK), Lyt-2 (CD8; Becton 
Dickinson & Co., Sunnyvale, CA), and L3T4 (CD4; Pharmingen). 
The cells were washed twice and resuspended in complete IMDM. 
Sheep anti-rat IgG (Fc) conjugated immunomagnetic beads (Dynal, 
Oslo, Norway) were added at a cell/bead ratio of 1:20, and in- 
cubated at 4~  for 30 rain. Labeled cells (Lin +) were removed by 
a magnetic particle concentrator (Dynal), and the Lin- cells were 
recovered from the supernatant. 
Lin-Scal + cells were purified as described by others (2,  25). 
Briefly, 4-6 x  107 Lin- cells were resuspended per milliliter of 
complete IMDM. The cells were incubated for 30 min on ice with 
either FITC-conjugated anti-mouse Ly-6A/E Ab (Pharmingen) 
directed against the Ly6A/E antigen (Sca-1) or an isotype-matched 
control Ab.  The cells were washed twice, and Lin-Sca-1 + cells 
were sorted on a cell sorter (Epics Elite; Coulter Electronics, Hia- 
leah,  FL) equipped with a 488-nm tuned argon laser set to give 
a power of 15 mW, with a rate of 1,500-2,000 cells/s. Lin- cells 
falling into median right angle scatter and median to high forward 
scatter were analyzed for Sca-1 expression,  and cells faring into 
both regions were selected.  Light scatter was collected through 
a 488-nm band pass filter and the FITC fluorescence was collected 
through a 488-nm-long pass filter and a 525-nm band pass filter. 
The final recovery of Lin-Sca-1 + cells was 0.05-0.1% of the ini- 
tial number of bone marrow cells. 
High Proliferative  Potential Colony-forming Cell (HPP-CFC)  Assay. 
The HPP-CFC assay was performed as previously described by others 
(26). Alpha modification of Eagle's MEM (Gibco) supplemented 
with  20%  FCS  (Sera Lab)  was  used  for all  HPP-CFC  assays. 
Cytokines were incorporated into a 1-ml underlayer in 35-mm Petri 
dishes at a maximum of 3 % of the culture volume, and calls were 
incorporated into a 0.5-ml overlayer. The final concentration of sea- 
plaque agarose (FMC BioProducts, Inc., Rockland, ME) was 0.5% 
in the underlayer and 0.3% in the overlayer. Cultures were gassed 
with  5%  02/5%  CO2/90%  N2  and  incubated  at  37~  for 
12-14 d. HPP-CFC colonies were scored as dense colonies with 
a diameter of >0.5 mm and containing >50,000 cells. 
Single-cell Proliferation Assay.  Lin-Sca-1 + cells were seeded in 
Terasaki plates (Nunc, Kamstrup, Denmark) at a concentration of 
one cell per well in a volume of 20/~1 complete IMDM. The wells 
were scored for proliferation after 12 d of incubation at 37~  5% 
CO2 in air. 
Cell Phenotyping.  Lin-Sca-1 + cells were seeded  in  complete 
IMDM at 500 cells per ml, or one cell per well,  and incubated 
for 12 d with cytokines as indicated at 37~  5% CO2 in air. Cell 
morphology was determined following Giemsa staining of  cytospin 
preparations. 
Results and Discussion 
Proliferation of Committed Lin-  Progenitors Is Not Affected 
by IL-7.  In agreement with previous studies (15) we found 
that IL-7 (0.02-200 ng/ml) did not affect CSF-1, GM-CSF, 
G-CSF,  or IL-3-induced proliferation of committed  Lin- 
bone marrow cells plated individually, and no colony forma- 
tion was  observed in the presence of IL-7 alone (Table 1). 
Similarly, IL-7 had no effect on the colony growth from un- 
fractionated bone marrow cells (data not  shown). 
CSF-induced Proliferation of Single Lin-Sca-1 + Cells Is En- 
hanced by IL-7.  The Lin-Sca-1 + cells are highly enriched 
in immature murine hematopoietic progenitor cells (2, 25, 
27, 28), and the CSFs have been demonstrated to induce in 
vitro myeloid colony formation of Lin-Sca-1 + cells (5-7). 
To investigate whether IL-7 directly could affect CSF-induced 
colony formation from primitive hematopoietic progenitor 
cells,  single Lin-Sca-1 + cells were cultured with CSFs in the 
presence or absence oflL-7 (Table 2). In agreement with pre- 
viously published  reports  (6,  7),  the  only single  cytokine 
capable of inducing significant proliferation of Lin-Sca-1 + 
cells was IL-3, Whereas IL-7 alone induced no colony for- 
mation, potent synergistic effects were observed when IL-7 
was combined with IL-3, increasing IL-3-responding pro- 
genitors threefold. Furthermore, whereas CSF-1 and GM-CSF 
as single factors induced no colony formation of Lin-Sca-1 + 
cells, significant numbers of colonies were formed when IL-7 
was combined with CSF-1 or GM-CSF (mean 11 and 8, respec- 
tively;  Table 2).  In  contrast,  IL-7  did not  synergize with 
G-CSF. Finally, IL-7 enhanced colony formation up to four- 
fold in response to several CSF combinations (Table 2). The 
IL-7-induced synergy on CSF-stimulated colony formation 
Table  1.  Effects  of rhlL-7 on the Proliferation of Single Lin-  Cells 
Positive 
Growth factors  wells/300 
IL-7 200 ng/ml  0  +  0 
CSF-1  17  _+  3 
CSF-1  +  200 ng/ml IL-7  18  +  4 
CSF-1  +  20 ng/ml IL-7  17  + 3 
CSF-1  +  2 ng/ml IL-7  16  _+  2 
CSF-1  +  0.2 ng/ml IL-7  18  _+  3 
CSF-1  +  0.02 ng/ml IL-7  16  _+ 3 
GM-CSF  17  _+ 3 
GM-CSF  +  200 ng/ml IL-7  18  +  4 
IL-3  19  _+ 3 
IL-3  +  200 ng/ml IL-7  19  +  3 
G-CSF  8  +_  2 
G-CSF  +  200 ng/ml IL-7  8 +_ 2 
CSF-1  +  GM-CSF  16  _+ 3 
CSF-1  +  GM-CSF  +  200 ng/ml IL-7  15  _+ 3 
Lin- cells were isohted as described  in Materials and Methods and plated 
in Terasaki plates at a concentration of one cell per well in 20 #1, in the 
presence or absence of purified rhIL-7 and predetermined optimal con- 
centrations of purified recombinant CSFs. Wells were scored for colo- 
nies (>10 cells) after 7 d of incubation at 37~  5% COz in air. Results 
presented represent the means _+ SEM of four experiments. 
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Growth factors  1  2 
Degree of proliferation 
Total No.  colonies/ 
3  4  5  300 wells 
IL-7 200  ng/ml  0  0 
IL-3  2  2 
IL-3  +  200  ng/ml IL-7  6*  6 
CSF-1  0  0 
CSF-1  +  200 ng/ml IL-7  3*  2* 
GM-CSF  0  0 
GM-CSF  +  200 ng/ml IL-7  1  1 
G-CSF  0  0 
G-CSF  +  200 ng/ml IL-7  0  0 
CSF-1  +  IL-3  2  3 
CSF-1  +  IL-3  +  200 ng/ml IL-7  2  2 
GM-CSF  +  IL-3  2  2 
GM-CSF  +  IL-3  +  200 ng/ml IL-7  3  4 
G-CSF  +  IL-3  7  8 
G-CSF  +  IL-3  +  200 ng/ml IL-7  4  8 
CSF-1  +  G-CSF  3  8 
CSF-1  +  G-CSF  +  200 ng/ml IL-7  3  3 
CSF-1  +  GM-CSF  2  2 
CSF-1  +  GM-CSF  +  200 ng/ml IL-7  5  2 
CSF-1  +  GM-CSF  +  100 ng/ml IL-7  3  2 
CSF-1  +  GM-CSF  +  50 ng/ml IL-7  4  3 
CSF-1  +  GM-CSF  +  20 ng/ml IL-7  3  3 
CSF-1  +  GM-CSF  +  2 ng/ml IL-7  2  3 
CSF-1  +  GM-CSF  +  0.2 ng/ml IL-7  1  3 
CSF-1  +  GM-CSF  +  0.02  ng/ml IL-7  1  2 
0  0  0  0+0 
3  1  0  9+1 
6  6*  3*  27  _+  3" 
0  0  0  0+0 
3"  2*  0  11  _+  3* 
0  0  0  0+0 
2*  3"  1"  8  -+  2" 
0  0  0  0_+0 
0  0  0  0_+0 
7  15  5  31  _+  3 
3  21  39"  67  _-4- 9* 
5  2  3  14_+3 
6  6*  26*  45  _+  3* 
10  5  2  32  _+  6 
6  9  13"  40  _+  7 
10  11  0  31  _+  4 
10  21  9*  44  _+  4 
2  2  0  8_+1 
3  10"  13"  33  _+  4" 
4  9*  12"  30  _+  5* 
2  6*  10"  25  _+  4* 
4  8*  7*  23  _+  4* 
2  1  2*  10  +  2 
1  1  1  7-+2 
2  2  0  7+1 
The Lin-Sca-1 § cells were plated in Terasaki plates at a concentration of one cell per well in 20/~1 IMDM supplemented with 20% FCS. Cultures 
were incubated in the presence or absence of rhlL-7 and predetermined optimal concentrations of the CSFs as indicated. Wells were scored for cell 
growth after 12-d incubation at 37~  5% CO2 in air. Scoring criteria: 1, 50 cells-10% of well covered by cells; 2, cells covering 10-25% of the 
well; 3, cells covering 25-50% of well; 4, cells covering 50-95% of the well; 5, complete confluency of the well. The results presented represent 
the means (means _+ SEM for total number of colonies) of at least three experiments, with a total of at least 900 wells scored per group. Statistical 
analysis was performed using Student's t test comparing colony formation in the absence and presence of rhlL-7. 
*p <0.05. 
from single Lin-Sca-1 + cells was concentration dependent 
with maximum stimulation observed at 100-200 ng/ml, and 
an EDs0 of 2-20 ng/ml  (Table  2). 
The size of the colonies generated by hematopoietic pro- 
genitors is considered to be indicative of the maturity of the 
progenitor cell investigated, with immature progenitor cells 
generating large colonies, and more committed progenitors 
forming smaUer colonies or dusters (26, 29).  Interestingly, 
when  colonies  formed  by  single  Lin-Sca-1 +  cells  were 
scored based on the degree of cell proliferation (Table 2), it 
became apparent that IL-7 preferentially stimulated forma- 
tion of large colonies,  that is those covering >50%  of the 
wells (three- to ninefold increase), and in particular colonies 
giving complete confluency of the wells (six- to ninefold in- 
crease).  For instance,  GM-CSF plus IL-3 stimulated forma- 
tion  of only three  colonies completely covering the  well, 
whereas 26 were observed upon addition of IL-7. Similarly, 
CSF-1 plus GM-CSF stimulated no colonies with complete 
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HPP-CFCs/400  Lin-Sca-1 + cells 
-  IL-7  +  IL-7  +  IL-7 
Growth factors  (200 ng/ml)  (50 ng/ml) 
None  0  _+  0  0  -+  0  ND 
IL-3  1  _+  0  9  _+  1"  ND 
CSF-1  +  IL-3  14  _+  4  27  +  2"  ND 
CSF-1  +  G-CSF  7 _+  1  20  _+  1"  ND 
CSF-1  +  GM-CSF  3  _+  1  19  _+  3*  16  _+  1" 
CSF-1  +  GM-CSF  +  anti-IL-7  4  _+  0  ND  5 +_  1 
Lin-Sca-1 + cells were plated in triplicate in the HPP-CFC assay (400 cells/dish) as described  in Materials and Methods. HPP-CFC colonies (tight 
colonies  with a diameter ;>0.5 mm) were scored after 12 d of incubation at 37~  5% O2, 5% CO2 and 90% N2.  A neutralizing mouse anti-hu- 
man IL-7 Ab (Genzyme Corp.) was used at 25/~g/ml.  No effect on IL-7-induced growth of HPP-CFC was observed when an isotype-matched 
control Ab was used (data not shown). Results presented are the means  _+  SEM  of at least  three experiments. Statistical analysis  was performed 
using Student's t test, comparing colony formation in the absence  and presence  of rhlL-7. 
" p  <0.05. 
confluency in the absence of IL-7, whereas 13 were observed 
in the presence of IL-7. In contrast, the number of small colo- 
nies was not increased by IL-7, suggesting that IL-7 prefer- 
entially enhances CSF-induced colony formation from im- 
mature hematopoietic progenitor cells. 
IL-7 Synergizes with the CSFs to Increase HPP-CFC Colony 
Formation from  Lin-Sca-i +  Cells.  Although  Lin-Sca-1 + 
bone marrow cells contain pluripotent hematopoietic stem 
cells, some heterogeneity has been demonstrated within the 
population (7, 25, 27, 28). Since the HPP-CFC assay detects 
some of the most immature hematopoietic progenitor cells 
measurable in vitro (26, 29), we next investigated the ability 
of IL-7 to affect the cloning frequency of HPP-CFCs. IL-7 
increased the number of HPP-CFC colonies up to ninefold 
when Lin-Sca-1 § cells were stimulated with different com- 
binations of CSFs (Table 3). The IL-7-induced enhancement 
of HPP-CFC colony formation was blocked in the presence 
of an anti-human IL-7  Ab (Genzyme Corp., Cambridge, 
MA), demonstrating that the observed synergy was induced 
specifically  by IL-7, and not by possible contaminants (Table 3). 
IL-7 Does Not Affect CSF-induced Myeloid Differentiation of 
Lin-Sca-1 + Cells.  To determine whether IL-7 also could 
affect  the myeloid differentiation induced by CSFs,  Lin- 
Sca-1 + cells were grown in liquid culture with CSFs, in the 
presence  or absence of IL-7. After 12-14  d of incubation, 
cytospin preparations were analyzed morphologically (Table 
4). Only granulocytes and macrophages were observed in the 
cultures,  and none of the investigated CSF combinations 
resulted in the formation of lymphoid progeny, either in the 
absence or presence of IL-7. Although IL-7 increased the total 
number of cells up to 50-fold, the relative contributions of 
granulocytes and macrophages observed were not significantly 
affected by IL-7 (Table 4). Furthermore, only a low number 
of blasts (<2%) were observed in the cultures, and their fre- 
quency was not influenced by the presence of IL-7 (data not 
shown). These observations in bulk liquid culture were fur- 
ther supported by isolation of single Lin-Sca-1 + cell dones, 
demonstrating absence of lymphoid colonies,  and the rela- 
tive proportions of CFU-G, CFU-M, and mixed CFU-GM 
colonies unaltered by IL-7. For instance, IL-3 alone induced 
Table  4.  Effects  of rklL-7  on  Differentiation  of Lin-Sca-1 + Bone Marrow Cells 
Percent  Percent 
Growth factors  Cells/ml  Fold increase  granulocytes  macrophages 
IL-3  7.2  x  104  50  +  4  50  _+  4 
IL-3  +  IL-7  1.1  x  10  s  15  48  _+  6  52  +  6 
CSF-1  +  GM-CSF  5.0  x  104  16  _+  3  84  _+  3 
CSF-1  +  GM-CSF  +  IL-7  2.6  x  106  52  15  +  2  85  +  2 
Lin-Sca-1 + cells were seeded  in liquid culture at 500 cells/ml in IMDM with 20% FCS.  Cultures were stimulated with the cytokines indicated 
at predetermined optimal concentrations and rhlL-7 was used at 200 ng/ml. Cells  were harvested after 12 d of incubation at 37~  5%  CO2 in 
air, and cell morphology was determined after Giemsa staining of cytospin preparations. Results represent means  _+  SEM of three separate experiments. 
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the parallel numbers in the presence of IL-3 plus IL-7 (200 
ng/ml) were 12, 26, and 62%, respectively. Similarly, of the 
single-cell  Lin-Sca-1 + clones induced by CSF-1 plus G-CSF 
(plus 200 ng/ml IL-7), 0% (0%) were CFS-G, 80% (84%) 
CFU-M,  and 20%  (16%)  CFU-GM. 
Since the in vitro conditions in the present study were op- 
timized for myelopoiesis, it is possible that IL-7 under other 
conditions might stimulate Lin-Sca-1 + cells to lymphopoi- 
esis as well. In support of this, a recent in vitro study demon- 
strated that  individual  Lin-Sca-1 + cells could differentiate 
along the myeloid as well as the B-lymphoid lineage (30). 
This report demonstrates that IL-7 has potent stimulatory 
effects on early myelopoiesis in synergy with CSF-1, IL-3, 
or GM-CSF. Furthermore, the single-cell assays indicate that 
the effect of IL-7 is directly mediated,  although  autocrine 
mechanisms cannot be excluded. Two recently published in 
vivo studies (22, 23), support tl~ese in vitro data by demon- 
strating that IL-7, in addition to having pronounced effects 
on lymphopoiesis, also affects myelopoiesis.  One of the studies 
(23) also reported an increase in peripheral myeloid cells after 
IL-7 administration.  Furthermore, experiments on primitive 
human hematopoietic progenitor cells in vitro demonstrate 
that IL-7 enhances early human myelopoiesis as well (Jacobsen, 
F.  W.,  unpublished  data).  Thus,  in  conclusion,  IL-7 is a 
cytokine with effects on lymphopoiesis and myelopoiesis,  and 
can no longer be regarded as a lymphoid lineage-restricted 
cytokine. 
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